{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:12Z","timestamp":1786118652349,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/jcp.0b013e3180582439","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T04:05:46Z","timestamp":1178683546000},"page":"289-294","source":"Crossref","is-referenced-by-count":21,"title":["The Effectiveness of Intramuscular Biperiden in Acute Akathisia"],"prefix":"10.1097","volume":"27","author":[{"given":"Bora","family":"Baskak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Cem","family":"Atbasoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halise Devrimci","family":"Ozguven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meram Can","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Kemal","family":"Gogus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1742-1241.1996.tb09548.x","article-title":"Drug induced akathisia revisited.","volume":"50","author":"Chung","year":"1996","journal-title":"Br J Clin Pract"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archpsyc.1994.03950120035007","article-title":"Clinical characteristics and predisposing factors in acute drug induced akathisia.","volume":"51","author":"Sachdev","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"R3-10-20210128","first-page":"1","article-title":"The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia.","volume":"13","author":"Atbasoglu","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R4-10-20210128","first-page":"339","article-title":"Akathisia and violence.","volume":"180","author":"Crowner","year":"1990","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002826-200005000-00008","article-title":"Akathisia and exacerbation of psychopathology: a preliminary report.","volume":"23","author":"Duncan","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004850-200015040-00004","article-title":"Clinic correlates of akathisia in acute psychiatric inpatients.","volume":"15","author":"Berardi","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/oxfordjournals.schbul.a007027","article-title":"The causes of underdiagnosing akathisia.","volume":"29","author":"Hirose","year":"2003","journal-title":"Schizophr Bull"},{"issue":"7352","key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/bmj.324.7352.1506","article-title":"Lesson of the week: akathisia: overlooked at a cost.","volume":"324","author":"Akagi","year":"2002","journal-title":"BMJ"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0006-3223(88)90260-0","article-title":"Propranolol in the treatment of neuroleptic-induced akathisia in schizophrenics: a double blind placebo-controlled study.","volume":"24","author":"Kramer","year":"1988","journal-title":"Biol Psychiatry"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1192\/bjp.149.1.42","article-title":"A controlled assessment of propranolol in the treatment of neuroleptic induced akathisia.","volume":"149","author":"Adler","year":"1986","journal-title":"Br J Psychiatry"},{"issue":"6","key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4088\/JCP.v63n0610","article-title":"Immediate effect of intravenous diazepam in neuroleptic-induced acute akathisia: an open label study.","volume":"63","author":"Hirose","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00004714-200112000-00013","article-title":"Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.","volume":"21","author":"Fischel","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-1781(84)90040-4","article-title":"Use of clonidine in treating neuroleptic-induced acute akathisia.","volume":"13","author":"Zubenko","year":"1984","journal-title":"Psychiatry Res"},{"issue":"4","key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00004714-198408000-00010","article-title":"Development of tolerance to the therapeutic effect of amantadine on akathisia.","volume":"4","author":"Zubenko","year":"1984","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000084027.22282.16","article-title":"Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.","volume":"23","author":"Poyurovsky","year":"2003","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4088\/JCP.v65n1118","article-title":"Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.","volume":"65","author":"Lerner","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-200501000-00005","article-title":"The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study.","volume":"20","author":"Gross-Isseroff","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1192\/bjp.143.2.139","article-title":"Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.","volume":"143","author":"Braude","year":"1983","journal-title":"Br J Psychiatry"},{"key":"R20-10-20210128","first-page":"CD003727","article-title":"Anticholinergics for neuroleptic induced akathisia.","volume":"3","author":"Lima","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-10-20210128","first-page":"CD003727","article-title":"Anticholinergics for neuroleptic-induced acute akathisia.","volume":"1","author":"Lima","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients.","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia.","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1176\/ajp.134.7.759","article-title":"Clinical research techniques in tardive dyskinesia.","volume":"134","author":"Fann","year":"1977","journal-title":"Am J Psychiatry"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale.","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties.","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0447.1983.tb00339.x","article-title":"Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia: a double-blind, cross-over study with placebo.","volume":"67","author":"Friis","year":"1983","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00002826-199308000-00004","article-title":"Intravenous benztropine and propranolol challenges in acute neuroleptic-induced akathisia.","volume":"16","author":"Sachdev","year":"1993","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"R30-10-20210128","first-page":"283","article-title":"A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis.","volume":"29","author":"Adler","year":"1993","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"R31-10-20210128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2190\/RAFD-AXDF-RJAD-FL1R","article-title":"Intravenous biperiden in akathisia: an open pilot study.","volume":"30","author":"Hirose","year":"2000","journal-title":"Int J Psychiatry Med"},{"key":"R32-10-20210128","first-page":"1077","article-title":"Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.","volume":"1071-","author":"Poyurovsky","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.174.3.238","article-title":"Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study.","volume":"174","author":"Poyurovsky","year":"1999","journal-title":"Br J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/jcp.0b013e3180582439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:37:19Z","timestamp":1786034239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200706000-00010"}},"subtitle":["A Double-Blind, Randomized, Placebo-Controlled Study"],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3180582439","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}